Anzeige
Mehr »
Login
Donnerstag, 09.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Vor Neubewertung: Kupfer-Geheimtipp veröffentlich in dieser Sekunde sensationelle Bohrergebnisse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
255 Leser
Artikel bewerten:
(1)

CQ Medical (formerly CIVCO Radiotherapy and Qfix) is Exhibiting New Brand and Expanded Product Portfolio at ESTRO 2024

CORALVILLE, Iowa, April 24, 2024 /PRNewswire/ -- CQ Medical, the new global leader in patient radiotherapy positioning and healthcare innovations that advance human care, will exhibit its innovative and patented solutions during the annual ESTRO Congress in Glasgow, United Kingdom, from 3 to 6 May 2024.

CQ Medical marks a pivotal transformation for CIVCO Radiotherapy and Qfix, who joined forces in October 2022. CQ Medical is derived from the company's Care Quotient: IQ + EQ = CQ. It follows their philosophy of applying intelligence and empathy to everything they make and do.

The company encourages attendees to visit booth #820 to see how two legacy companies are integrating their market-leading solutions, uniquely combining medical technology with patient empathy, to help achieve better patient outcomes. Two special product unveilings will take place on Friday, 3 May at 19:18, which you will want to attend.

SBRT Immobilization Solutions, including the new Body Pro-Lok ONEBridge compatible with Alta
CQ has combined two best-in-class products to create one remarkable SBRT positioning solution. The market-leading ONEBridge fits most patients, immobilizing and improving positioning and respiratory restriction for more accurate treatment. Current Alta Multipurpose Device users can upgrade their respiratory compression systems with the Body Pro-Lok ONEBridge.

Symphony® Imaging, Treatment & Transfer Solutions
Symphony solutions facilitate smooth patient transfers between imaging modalities and treatment or procedure platforms without repositioning the patient. Visit the company to learn about their innovations with the Lithotomy AirShuttle for brachytherapy and the Alta AirShuttle for Adaptive customized cancer care workflow solutions.

SRS Immobilization Solutions
The Encompass and Solstice SRS Immobilization Systems are highly advanced, non-invasive solutions designed for precisely targeted brain, head, and neck treatments. The Encompass is validated for HyperArc and provides setup confidence and comfort with the Integrated Shim system. Solstice features unique variable pitch capability, increasing setup and treatment flexibility.

Thermoplastics including Fibreplast® and Integrated Shim
CQ offers various thermoplastic options, including Fibreplast, a premium proprietary thermoplastic that is more rigid and shrinks less than standard thermoplastic. The Integrated Shim feature, which increases workflow efficiencies and patient comfort, allows for customizable immobilization.

Largest Selection of Specially Designed Fiducial Markers
CQ has the largest selection of specially designed fiducials that provide a highly effective method of ensuring accurate target localization for tumors or organs that move in respect to external anatomy, including the new BioXmark® liquid fiducial marker.

Proton Solutions, including Pediatric Options
CQ has set a standard in proton therapy solutions with a range of market-leading couchtops, head & neck immobilization, and additional disease site positioning solutions, including a complete pediatric offering.

About CQ Medical
CQ Medical is the global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. With primary locations in Iowa and Pennsylvania and employees worldwide, the company has more than 80 years of combined experience bringing advanced hardware and consumables for patient immobilization and positioning, fiducial markers, couchtops, and patient care products to the market. Visit CQmedical.com for more information.

For further information, please contact:
Shelli Locklear, Director of Marketing, at +1 319.248.6619 or Shelli.Locklear@CQmedical.com

COPYRIGHT © 2024. This press release contains information about products that may or may not be available in particular countries. These products may not be licensed in accordance with Canadian law. Each country has specific laws and regulations governing the commercialization of medical devices and the communication of information regarding medical devices in printed and digital media. Products appearing in this press release or on our website may or may not have received approval, clearance, or marketing authorization by a governmental regulatory body in any particular country or may have received approval, clearance, or marketing authorization for different indications and restrictions in different countries or may be for investigational use only. BoS, Fibreplast, Symphony and Qfix are registered trademarks of Qfix. AirShuttle, Alta, Encompass, and Integrated Shim are trademarks of Qfix. CIVCO is a registered trademark of CIVCO Medical Solutions. CIVCO Radiotherapy, CIVCO RT, Body Pro-Lok ONE, ONEBridge, and Solstice are trademarks of Medtec LLC. BioXmark is a registered trademark of Nanovi A/S. HyperArc is a trademark of Varian Medical Systems. CQ2024D76 Rev. 0

Cision View original content:https://www.prnewswire.co.uk/news-releases/cq-medical-formerly-civco-radiotherapy-and-qfix-is-exhibiting-new-brand-and-expanded-product-portfolio-at-estro-2024-302126279.html

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.